Elanco Animal Health (ELAN) EBIT Margin (2017 - 2026)
Elanco Animal Health (ELAN) posted EBIT Margin of 21.23% for Q1 2026, up 651.86% sequentially from 3.85% in Q4 2025, and up 111.0% YoY from 10.06% in Q1 2025.
Elanco Animal Health (ELAN) EBIT Margin (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported EBIT Margin for 10 years, with the latest figure at 21.23% in Q1 2026.
- Quarterly EBIT Margin rose 111.0% year-over-year to 21.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.45% (up 2988.0% YoY) and the FY2025 annual result came in at 11.83%, up 4596.0% from the prior year.
- EBIT Margin advanced to 21.23% in Q1 2026 per ELAN's latest filing, from 3.85% in the prior quarter.
- Over five years, EBIT Margin peaked at 21.23% in Q1 2026 and troughed at 148.31% in Q3 2023.
- A 5-year average of 31.67% and a median of 41.74% in 2024 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2023 and 2024: EBIT Margin plunged 9802 bps in 2023, then soared 15482 bps in 2024.
- Over 5 years, EBIT Margin stood at 54.52% in 2022, then retreated by 14 bps to 62.13% in 2023, then increased by 13 bps to 54.12% in 2024, then surged by 93 bps to 3.85% in 2025, then surged by 652 bps to 21.23% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 21.23%, 3.85%, and 12.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 3.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.13% |
| Mar 31, 2026 | 21.23% |
| Dec 31, 2025 | -3.85% |
| Sep 30, 2025 | 12.49% |
| Jun 30, 2025 | 17.73% |
| Mar 31, 2025 | 20.12% |
| Dec 31, 2024 | -54.12% |
| Sep 30, 2024 | 6.50% |
| Jun 30, 2024 | -44.51% |
| Mar 31, 2024 | -41.74% |
| Dec 31, 2023 | -62.13% |
| Sep 30, 2023 | -148.31% |
| Jun 30, 2023 | -48.53% |
| Mar 31, 2023 | -30.71% |
| Dec 31, 2022 | -54.52% |
| Sep 30, 2022 | -50.29% |
| Jun 30, 2022 | -42.38% |
| Mar 31, 2022 | -35.40% |
| Dec 31, 2021 | -57.10% |
| Sep 30, 2021 | -55.88% |